Elite Elevators
Buying intent
39 tracked signals | Top 15 topics are below | Sales is carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Elite Elevators's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
18d ago
18d ago
2d ago
18d ago
18d ago
18d ago
23d ago
23d ago
26d ago
22d ago
18d ago
18d ago
26d ago
22d ago
22d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Elite Elevators
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
Primary products / business lines
LinkedIn company profileEstablished in 2013, Elite Elevators is a premium home elevator company in India. Headquartered in Chennai, we have pan-India operations with a network of 20 Experience Centres across the country. To bring to India the best home elevators, we’ve partnered with TK Access Solutions - a world leader in home elevator technology and manufacturing. Engineered in Germany and made in Italy, our home eleva
Top accounts researching Elite Elevators
names withheld on the public pageThese are companies whose own people brought up Elite Elevators unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
75,708 companies · 411,263 people are researching Hiring
Elite Elevators's own team shows 8 signals on this topic. No one outside Elite Elevators has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Business Development18,585 cos · 69,375 people
- Career Development71,482 cos · 516,730 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Sales — 4 people
What's been said
public posts by Elite Elevators's teamNo public post naming Elite Elevators has surfaced in the past year, so this is what Elite Elevators's own team is posting about publicly — their topics, in their words.
𝗣𝗖𝗢𝗦 𝗶𝘀 𝗡𝗼𝘄 𝗣𝗠𝗢𝗦 Polycystic Ovary Syndrome (PCOS) has long been one of the most common hormonal conditions in women, affecting over 170 million people worldwide. But despite how widely used the term became, experts now say it was misleading in how it described the disease. A new name has now been introduced: Polyendocrine Metabolic Ovarian Syndrome (PMOS). This update, published in The Lancet and supported by international medical organizations and U.S. academic leaders (including experts from CU Anschutz), is being described as a major correction in how the condition is understood. 𝗪𝗵𝘆 𝘁𝗵𝗲 𝗼𝗹𝗱 𝗻𝗮𝗺𝗲 𝘄𝗮𝘀 𝗺𝗶𝘀𝗹𝗲𝗮𝗱𝗶𝗻𝗴: The term “polycystic ovary syndrome” implied that the condition: 🔹 was mainly an ovarian problem 🔹 was defined by ovarian cysts But modern evidence shows this is not accurate. In reality: 🔹 many patients have no ovarian cysts at all 🔹 some are told their ultrasound is normal despite clear symptoms 🔹 what is often seen on scans are immature follicles, not true cysts Over time, this misunderstanding narrowed medical focus to the ovaries, leading to: 🔹 delayed diagnosis 🔹 overemphasis on reproductive issues 🔹 under-recognition of broader health effects 𝗪𝗵𝗮𝘁 𝗣𝗠𝗢𝗦 𝗮𝗰𝘁𝘂𝗮𝗹𝗹𝘆 𝗿𝗲𝗳𝗹𝗲𝗰𝘁𝘀: The new name shifts focus to the full disease picture. PMOS is now understood as a multisystem disorder, involving: 🔹Hormonal imbalance (polyendocrine dysfunction) 🔹Metabolic dysfunction (especially insulin resistance and weight changes) 🔹Reproductive effects (irregular ovulation and infertility) 🔹Skin manifestations (acne, hirsutism) 🔹Psychological effects (anxiety, depression) 🔹 Long-term cardiometabolic risks 𝗪𝗵𝘆 𝗲𝘅𝗽𝗲𝗿𝘁𝘀 𝗽𝘂𝘀𝗵𝗲𝗱 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗰𝗵𝗮𝗻𝗴𝗲: The change is the result of more than a decade of international collaboration involving clinicians, researchers, and patients. Experts, including endocrinology leaders such as those at CU Anschutz and pediatric endocrinologist Melanie Cree, highlighted that: 🔹the old term caused misunderstanding and stigma 🔹it contributed to missed or delayed diagnoses 🔹it particularly affected how fertility concerns were framed Large global consultations, surveys, and workshops involving tens of thousands of responses repeatedly showed the same issue: the name did not reflect patient reality.
May 2026